Person who experienced the adverse event (patient)
Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6816940 | 7476623 | I | 6816940-X | 20100327 | 20100617 | 20100630 | EXP | TPG2010A00398 | TAKEDA PHARMACEUTICALS NORTH AMERICA. | 76 | YR | M | N | 20100628 | SWITZERLAND |
Drug(s) used by person
Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
---|---|---|---|---|---|---|---|---|---|---|---|
6816940 | 1014034917 | PS | ACTOS | 1 | ORAL | 45 MG (45 MG, 1 IN 1 D), PER ORAL | Y | D | 21073 | ||
6816940 | 1014089817 | SS | LANTUS | 1 | SUBCUTANEOUS | 10 IU SUBCUTANEOUS | |||||
6816940 | 1014089823 | SS | AMARYL | 1 | ORAL | 4 MG (4 MG, 1 IN 1 D) PER ORAL | |||||
6816940 | 1014089833 | SS | GLUCOPHAGE | 1 | ORAL | 1000 MG (1000 MG, 1 IN 1 D) PER ORAL | |||||
6816940 | 1014089836 | C | ASPIRIN | 1 | |||||||
6816940 | 1014089837 | C | TOLTERODINE TARTRATE | 1 | |||||||
6816940 | 1014089839 | C | PRAVASTATIN | 1 |
Indications of drugs used
Event ID | DRUG SEQ | INDI PT |
---|---|---|
6816940 | 1014034917 | DIABETES MELLITUS |
6816940 | 1014089817 | DIABETES MELLITUS |
Outcome of event
Event ID | OUTC COD |
---|---|
6816940 | HO |
Reactions reported
Event ID | PT |
---|---|
6816940 | HYPOGLYCAEMIA |
6816940 | SOMNOLENCE |
6816940 | UNRESPONSIVE TO STIMULI |
Reporting Sources (this data is often not reported and may therefore be missing here)
Event ID | RPSR COD |
---|---|
6816940 | HP |
6816940 | OTH |
Therapies reported
Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|
6816940 | 1014034917 | 20100327 | |||
6816940 | 1014089817 | 20100327 | |||
6816940 | 1014089823 | 20100327 | |||
6816940 | 1014089833 | 20100327 |